Featured Content
Alkermes said Nov. 18 that it will acquire Boston-based drugmaker Rodin Therapeutics for $100 million to expand its portfolio of…
Alkermes said Nov. 18 that it will acquire Boston-based drugmaker Rodin Therapeutics for $100 million to expand its portfolio of…